Table 4 Logistic regression for predicting response category “CR or PR” versus “SD or “PD”
From: Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
| Estimate | Std. Error | z value | Pr(>|z|) | |
|---|---|---|---|---|
| TumorType RCC | (reference) | – | – | – |
| TumorType Melanoma (versus RCC) | 1.50 | 0.50 | 3.01 | 0.0026 |
| TumorType NSCLC (versus RCC) | −0.13 | 0.53 | −0.25 | NS |
| IHC TPS ≥1% | 0.41 | 0.40 | 1.03 | NS |
| RNA-seq.L | 0.96 | 0.40 | 2.43 | 0.015 |
| RNA-seq.Q | 0.21 | 0.28 | 0.76 | NS |